T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes combo pill aims to beat single drugs in major trial
Disease control Not yet recruitingThis study tests whether starting treatment with two experimental drugs together (DWP16001 and DWC202518) works better than either drug alone for people with type 2 diabetes. About 510 adults will take the combo or a single drug for 24 weeks, and researchers will measure changes …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 17, 2026 07:26 UTC
-
Shocking diabetes treatment? new procedure aims to control blood sugar and fatty liver
Disease control Not yet recruitingThis study tests a procedure called ReCET for people with type 2 diabetes and fatty liver disease who haven't had good blood sugar control with pills. The procedure uses electrical pulses to treat the lining of the small intestine. The goal is to see if it can improve blood sugar…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New Triple-Drug diabetes pill aims for better blood sugar control
Disease control Not yet recruitingThis study tests a new once-daily tablet that combines three diabetes drugs (henagliflozin, retagliptin, and metformin) in Chinese adults with type 2 diabetes. About 300 participants will take the pill for 24 weeks to see how well it lowers blood sugar and check for side effects.…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Can a diabetes pill save your kidneys? major trial launches
Disease control Not yet recruitingThis study tests whether adding ganagliflozin tablets to standard care can slow kidney disease in people with type 2 diabetes and chronic kidney disease. About 1,244 adults will receive either the drug or a placebo for 120 weeks. The main goal is to measure changes in kidney func…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New combo therapy aims to improve diabetes management
Disease control Not yet recruitingThis study looks at adding a drug called Chiglitazar to standard SGLT-2 inhibitor treatment for adults with type 2 diabetes whose blood sugar is not well controlled. Researchers will track changes in blood sugar, heart, kidney, and liver health over time. About 3550 participants …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New triple therapy aims to shield kidneys in diabetes patients
Disease control Not yet recruitingThis study looks at whether adding a third drug (dulaglutide) to an existing two-drug combination can better protect the kidneys in Chinese adults with type 2 diabetes and mild-to-moderate chronic kidney disease. About 468 participants who are already on two kidney-protecting dru…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
New diabetes combo pill tested in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new combination pill for type 2 diabetes in 28 healthy Chinese adults. It has two parts: one checks if a high-fat meal changes how the drug enters the blood, and the other looks at what happens with repeated doses. The goal is to understand the drug…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
New diabetes combo pill put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis study checks if a new tablet that combines two diabetes drugs (Chiglitazar and Metformin) works the same as the standard separate tablets. It involves 64 healthy adults aged 18-45 who take a single dose under fed conditions. The goal is to see how the drug moves through the …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
New diabetes combo pill put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis study checks if a new tablet that combines two diabetes medicines (Chiglitazar and Metformin) works the same as taking them separately. It involves 24 healthy adults who take a single dose of each version under fed conditions. The goal is to measure how the drug moves throug…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated Jun 03, 2026 12:04 UTC